Diffusion-weighted magnetic resonance imaging for prediction of tumor response to neoadjuvant chemoradiotherapy using irinotecan plus S-1 for rectal cancer

By                

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1129-1134

Science Publishers

Access to resources Recommend Favorite

Imaging and targeted agents in gastrointestinal cancers: overview on perfusion- and diffusion-weighted magnetic resonance imaging and angiogenesis inhibitors

By Vandecaveye Vincent  

Targeted Oncology, Vol. 3, Iss. 2, 2008-04 ,pp. : 101-110

Springer Publishing Company

Access to resources Recommend Favorite

Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy

By Padhani Anwar  

Targeted Oncology, Vol. 5, Iss. 1, 2010-03 ,pp. : 39-52

Springer Publishing Company

Access to resources Recommend Favorite

The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer

By Lambrecht Maarten   Deroose Christophe   Roels Sarah   Vandecaveye Vincent   Penninckx Freddy   Sagaert Xavier   van Cutsem Eric   de Keyzer Frederik   Haustermans Karin  

Acta Oncologica, Vol. 49, Iss. 7, 2010-10 ,pp. : 956-963

Informa Healthcare

Access to resources Recommend Favorite

Ex vivo 1H and 31P magnetic resonance spectroscopy as a means for tumor characterization in ovarian cancer patients

By        

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 321-328

Spandidos Publications

Access to resources Recommend Favorite